{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-038272","form_type":"8-K","ticker":"ONCY","cik":"0001129928","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.988107+00:00","generated_at":"2026-05-15T07:56:30.179108+00:00","sec_items":["1.01","3.03","5.03","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Oncolytics Biotech completes redomestication to Nevada; adopts new equity plan and governance documents","bullets":["Redomestication from Canada to Nevada completed; common stock continues trading on Nasdaq under ONCY.","New CUSIP 68237V 103 and ISIN US68237V1035 effective April 1, 2026.","Board adopted 2026 Incentive Award Plan with 6.5M initial shares plus annual evergreen increase up to 6% of outstanding.","New indemnification agreements executed with all executive officers and directors.","Risk factor update warns of reduced stockholder rights under Nevada law, including exclusive forum provisions and no cumulative voting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-038272","json":"https://secwatch.observer/filing/0001104659-26-038272.json","markdown":"https://secwatch.observer/filing/0001104659-26-038272.md","text":"https://secwatch.observer/filing/0001104659-26-038272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/tm2610715d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:56:30.179108+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c9a1968f6ba4a562a9a0f9cb6664050d1699ac5d","claim":"ONCOLYTICS BIOTECH INC: Filed Articles of Incorporation and adopted Bylaws in connection with domestication from British Columbia to Nevada.","evidence_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001829126-26-004879","ticker":"SAGU","company_name":"Shreya Acquisition Group","filed_at":"2026-05-11T23:59:59+00:00","headline":"Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004879","json":"https://secwatch.observer/filing/0001829126-26-004879.json","markdown":"https://secwatch.observer/filing/0001829126-26-004879.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/0001829126-26-004879-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/shreyaacq_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/0001829126-26-004879-index.htm"}},{"accession":"0001193125-26-204723","ticker":"MTNE","company_name":"CH4 Natural Solutions Corp","filed_at":"2026-05-05T23:59:59+00:00","headline":"CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-204723","json":"https://secwatch.observer/filing/0001193125-26-204723.json","markdown":"https://secwatch.observer/filing/0001193125-26-204723.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/0001193125-26-204723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/0001193125-26-204723-index.htm"}},{"accession":"0001213900-26-051060","ticker":"CAII","company_name":"Collective Acquisition Corp. II","filed_at":"2026-05-04T23:59:59+00:00","headline":"Collective Acquisition Corp. II closes $220M IPO; units trade on Nasdaq","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-051060","json":"https://secwatch.observer/filing/0001213900-26-051060.json","markdown":"https://secwatch.observer/filing/0001213900-26-051060.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2115404/000121390026051060/0001213900-26-051060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2115404/000121390026051060/ea0288564-8k_collective2.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"On April 28, 2026, in connection with the Offering, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which became effective on April 28, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2115404/000121390026051060/0001213900-26-051060-index.htm"}},{"accession":"0001104659-26-051495","ticker":"IACQ","company_name":"Irenic Acquisition Corp.","filed_at":"2026-04-29T23:59:59+00:00","headline":"Irenic Acquisition Corp. closes $220M IPO; trust funded with $220M for business combination","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-051495","json":"https://secwatch.observer/filing/0001104659-26-051495.json","markdown":"https://secwatch.observer/filing/0001104659-26-051495.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2122505/000110465926051495/0001104659-26-051495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2122505/000110465926051495/tm269391d12_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"On April 27, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2122505/000110465926051495/0001104659-26-051495-index.htm"}},{"accession":"0001213900-26-049354","ticker":"CXII","company_name":"Churchill Capital Corp XII","filed_at":"2026-04-29T23:59:59+00:00","headline":"Churchill Capital Corp XII closes upsized $414M SPAC IPO; units trade on Nasdaq","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-049354","json":"https://secwatch.observer/filing/0001213900-26-049354.json","markdown":"https://secwatch.observer/filing/0001213900-26-049354.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2114227/000121390026049354/0001213900-26-049354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2114227/000121390026049354/ea0288158-8k_churchill12.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"On April 27, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 27, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2114227/000121390026049354/0001213900-26-049354-index.htm"}},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 1.01, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm"}},{"accession":"0001287032-26-000174","ticker":"PSEC","company_name":"PROSPECT CAPITAL CORP","filed_at":"2026-05-08T23:59:59+00:00","headline":"Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares","event_type":"other_material","sec_items":["1.01","3.03","5.03","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: governance_change","same SEC item: 1.01, 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001287032-26-000174","json":"https://secwatch.observer/filing/0001287032-26-000174.json","markdown":"https://secwatch.observer/filing/0001287032-26-000174.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287032/000128703226000174/0001287032-26-000174-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287032/000128703226000174/psec-20260508.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1287032/000128703226000174/0001287032-26-000174-index.htm"}},{"accession":"0001193125-26-211978","ticker":"JPM","company_name":"JPMORGAN CHASE & CO","filed_at":"2026-05-07T23:59:59+00:00","headline":"JPMorgan issues $3B of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-211978","json":"https://secwatch.observer/filing/0001193125-26-211978.json","markdown":"https://secwatch.observer/filing/0001193125-26-211978.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/0001193125-26-211978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/d903351d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm","comparable_excerpt":"On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/0001193125-26-211978-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}